The resultant 89Zr-PD-1 IgG synthesized was shown to efficiently bind to EL4 lymphoma cells that express high levels of PD-1, and the binding was completely blocked by excess cold antibody, confirming excellent target specificity. Here, PDCD1 is linked to lymphoma.